HFCAS OpenIR

浏览/检索结果: 共1条,第1-1条 帮助

已选(0)清除 条数/页:   排序方式:
Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Fu, Meng;  Feng, Chun-Mei;  Xia, Da-Qing;  Ji, Zi-Mei;  Xia, Huai-Ling;  Hu, Na-Na;  Leng, Zai-Jun;  Xie, Wang;  Fang, Yuan;  Cao, Le-Jie;  Zhang, Jun-Qiang
收藏  |  浏览/下载:32/0  |  提交时间:2022/12/23
savolitinib  MET exon 14 skipping  neoadjuvant therapy  non-small cell lung cancer  targeted therapy